BARNWELL INDUSTRIES INC (BRN) Fundamental Analysis & Valuation

NYSEARCA:BRN • US0682211000

1.22 USD
-0.06 (-4.69%)
At close: Mar 6, 2026
1.21 USD
-0.01 (-0.82%)
After Hours: 3/6/2026, 8:04:00 PM

This BRN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BRN. BRN was compared to 207 industry peers in the Oil, Gas & Consumable Fuels industry. BRN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. BRN Profitability Analysis

1.1 Basic Checks

  • In the past year BRN has reported negative net income.
  • In the past year BRN has reported a negative cash flow from operations.
  • In multiple years BRN reported negative net income over the last 5 years.
  • Of the past 5 years BRN 4 years had a positive operating cash flow.
BRN Yearly Net Income VS EBIT VS OCF VS FCFBRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

1.2 Ratios

  • BRN has a Return On Assets of -34.13%. This is amonst the worse of the industry: BRN underperforms 93.24% of its industry peers.
  • BRN has a worse Return On Equity (-101.36%) than 88.89% of its industry peers.
Industry RankSector Rank
ROA -34.13%
ROE -101.36%
ROIC N/A
ROA(3y)-18.33%
ROA(5y)-2.92%
ROE(3y)-49.72%
ROE(5y)-10.91%
ROIC(3y)N/A
ROIC(5y)N/A
BRN Yearly ROA, ROE, ROICBRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • BRN has a Gross Margin (31.98%) which is comparable to the rest of the industry.
  • BRN's Gross Margin has improved in the last couple of years.
  • BRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.71%
GM growth 5Y1.92%
BRN Yearly Profit, Operating, Gross MarginsBRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

5

2. BRN Health Analysis

2.1 Basic Checks

  • BRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BRN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for BRN has been increased compared to 5 years ago.
  • There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BRN Yearly Shares OutstandingBRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BRN Yearly Total Debt VS Total AssetsBRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • BRN has an Altman-Z score of 0.07. This is a bad value and indicates that BRN is not financially healthy and even has some risk of bankruptcy.
  • BRN's Altman-Z score of 0.07 is on the low side compared to the rest of the industry. BRN is outperformed by 65.70% of its industry peers.
  • There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.07
ROIC/WACCN/A
WACC8.79%
BRN Yearly LT Debt VS Equity VS FCFBRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

2.3 Liquidity

  • A Current Ratio of 1.11 indicates that BRN should not have too much problems paying its short term obligations.
  • The Current ratio of BRN (1.11) is comparable to the rest of the industry.
  • BRN has a Quick Ratio of 1.11. This is a normal value and indicates that BRN is financially healthy and should not expect problems in meeting its short term obligations.
  • BRN has a Quick ratio (1.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
BRN Yearly Current Assets VS Current LiabilitesBRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

0

3. BRN Growth Analysis

3.1 Past

  • BRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.15%.
  • BRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.91%.
  • Measured over the past years, BRN shows a decrease in Revenue. The Revenue has been decreasing by -5.34% on average per year.
EPS 1Y (TTM)-27.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.43%
Revenue 1Y (TTM)-32.91%
Revenue growth 3Y-20.49%
Revenue growth 5Y-5.34%
Sales Q2Q%-29.7%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRN Yearly Revenue VS EstimatesBRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

0

4. BRN Valuation Analysis

4.1 Price/Earnings Ratio

  • BRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRN Price Earnings VS Forward Price EarningsBRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRN Per share dataBRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. BRN Dividend Analysis

5.1 Amount

  • BRN has a Yearly Dividend Yield of 2.31%.
  • BRN's Dividend Yield is comparable with the industry average which is at 3.40.
  • BRN's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

  • BRN has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BRN Yearly Dividends per shareBRN Yearly Dividends per shareYearly Dividends per share 2022 2023 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
BRN Yearly Income VS Free CF VS DividendBRN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

BRN Fundamentals: All Metrics, Ratios and Statistics

BARNWELL INDUSTRIES INC

NYSEARCA:BRN (3/6/2026, 8:04:00 PM)

After market: 1.21 -0.01 (-0.82%)

1.22

-0.06 (-4.69%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-12
Earnings (Next)05-13
Inst Owners8.79%
Inst Owner Change6.07%
Ins Owners43.65%
Ins Owner Change10.48%
Market Cap15.30M
Revenue(TTM)14.24M
Net Income(TTM)-7.10M
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.07
P/FCF N/A
P/OCF N/A
P/B 2.18
P/tB 2.18
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS1.14
BVpS0.56
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.13%
ROE -101.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.98%
FCFM N/A
ROA(3y)-18.33%
ROA(5y)-2.92%
ROE(3y)-49.72%
ROE(5y)-10.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.71%
GM growth 5Y1.92%
F-Score2
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.71%
Cap/Sales 21.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 0.07
F-Score2
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)142.59%
Cap/Depr(5y)199.3%
Cap/Sales(3y)28.54%
Cap/Sales(5y)26.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.91%
Revenue growth 3Y-20.49%
Revenue growth 5Y-5.34%
Sales Q2Q%-29.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-517.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.66%
OCF growth 3YN/A
OCF growth 5YN/A

BARNWELL INDUSTRIES INC / BRN FAQ

What is the ChartMill fundamental rating of BARNWELL INDUSTRIES INC (BRN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BRN.


What is the valuation status of BARNWELL INDUSTRIES INC (BRN) stock?

ChartMill assigns a valuation rating of 0 / 10 to BARNWELL INDUSTRIES INC (BRN). This can be considered as Overvalued.


Can you provide the profitability details for BARNWELL INDUSTRIES INC?

BARNWELL INDUSTRIES INC (BRN) has a profitability rating of 2 / 10.